Philips Advanced Molecular Imaging is transforming patient care by providing low dose molecular and hybrid imaging solutions that enhance lesion detectability and allow the user to share diagnostic information virtually anytime, anywhere. We have made a lasting impact in nuclear medicine by introducing innovations such as Time-of-Flight PET, hybrid SPECT/CT and digital PET/CT. We continue to bring solutions in the field of nuclear medicine that enhance quantitative accuracy and enable new clinical applications for monitoring of cancer therapy response and studying diseases.
Supported by rigorous clinical evidence, Vereos is the world’s first and only fully digital, clinically proven, PET/CT solution . With proprietary Digital Photon Counting technology for outstanding advances all along the imaging chain, Vereos exemplifies an established total solution to reveal more, earlier, to help you improve patient care and manage costs.
The Philips Ingenuity TF PET/CT Time-of-Flight system leverages multiple technologies, collectively known as xPand⁵, that act together to enhance image quality and support quantification. These join CT advances like iPatient, iDose⁴, and metal artifact reduction for implants (O-MAR).